Our vision and values

Improving animal health has guided us in the early years of our company’s existence. We believe that research can be guided by the desire to improve human and animal health while being respectful of resources and the environment.

Based on the results obtained in animals, Urodelia is now entering a decisive phase: the development of its autologous therapeutic vaccine in human oncology.

banniere urodelia

URODELIA, INNOVATION FOR THE HEALTH OF TOMORROW

We develop innovative therapeutic treatments whose objective is to deliver a very high technological quality.

We excel in innovation to develop our competitiveness and serve the health of tomorrow.

We believe in partnerships to ensure the success and sustainability of the economic health of our business.

Urodelia is part of one of the most promising research pathways in immuno-oncology: the autologous therapeutic vaccine

  • Animal health
    A vaccine used in animals is now marketed in veterinary medicine under the name APAVAC
  • Human health
    A 5-year strategic plan that will lead to the confirmation in humans of the first conclusions obtained in animals